FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience

BACKGROUND: FOLFIRINOX has been shown to significantly increase both overall survival (OS) and progression-free survival (PFS) in metastatic pancreas cancer. There is limited data regarding the treatment of locally advanced pancreatic cancer. We present a retrospective study of patients with both lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chllamma, Muralidharan K, Cook, Natalie, Dhani, Neesha C, Giby, Kazim, Dodd, Anna, Wang, Lisa, Hedley, David W, Moore, Malcolm J, Knox, Jennifer J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023770/
https://www.ncbi.nlm.nih.gov/pubmed/27467054
http://dx.doi.org/10.1038/bjc.2016.222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023770/
https://www.ncbi.nlm.nih.gov/pubmed/27467054
http://dx.doi.org/10.1038/bjc.2016.222

Ejemplares similares